"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.

We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

Kai Beckmann, a member of the executive board and the CEO Electronics at Merck KgaA, discusses the use of AI in the ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

Merck (MRK) reachead $106.64 at the closing of the latest trading day, reflecting a +0.28% change compared to its last close.

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...